Introduction
The Haematology Unit was established in 1962. This Unit aims to develop new and advanced molecular cytogenetics techniques. It is involved in studies of haematological malignancies: gene rearrangement studies in leukaemia, cryptic rearrangements and masked translocations, characterisation of gene deletions in acute myeloid leukaemia by comparative genomic hybridization (CGH), detection of minimal residual disease in myeloid leukaemia and the monitoring of response to therapy using fluorescence in-situ hybridization (FISH) and molecular techniques.
Haematology unit activities divided by two parts:
I) Diagnostic
Hemato-Oncology
• Chromosome Analysis
• Leukaemia Mutation
• Acute Myeloid Leukaemia Mutation
• Chimerism
Genetic
• Thalassemia
• Genetic Disorder Disease
• Haemophilia B
II) Research
Research and Development
• Acute Myeloid Leukaemia (AML)
• Lymphoma
• Chronic Myeloid Leukaemia (CML)
• Childhood Leukaemia
• Multiple Myeloma
• Acute Lymphoblastic Leukaemia (ALL)
• Chronic Lymphocytic Leukaemia (CLL)
• Brain Tumor
Stem Cell
• induced Pluripotent Stem Cell (iPSC)
• Mesenchymal Stem Cell (MSC)
• Cancer Stem Cell
• Stem Cell Therapy
